Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon bought 30 shares of the company’s stock in a transaction dated Wednesday, January 22nd. The stock was bought at an average price of GBX 1,362 ($16.77) per share, for a total transaction of £408.60 ($503.02).
Johnson Matthey Trading Up 0.7 %
Johnson Matthey stock traded up GBX 10 ($0.12) during trading on Thursday, reaching GBX 1,367 ($16.83). 387,490 shares of the company were exchanged, compared to its average volume of 583,226. Johnson Matthey PLC has a 52-week low of GBX 1,295.54 ($15.95) and a 52-week high of GBX 1,917.07 ($23.60). The company has a market capitalization of £2.38 billion, a P/E ratio of 2,356.90, a PEG ratio of 49,242.50 and a beta of 0.95. The stock’s 50 day simple moving average is GBX 1,384.15 and its two-hundred day simple moving average is GBX 1,512.54. The company has a debt-to-equity ratio of 63.15, a current ratio of 1.45 and a quick ratio of 0.76.
Johnson Matthey (LON:JMAT – Get Free Report) last announced its quarterly earnings data on Wednesday, November 27th. The company reported GBX 57.40 ($0.71) earnings per share (EPS) for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.39%. On average, equities research analysts expect that Johnson Matthey PLC will post 173.4112903 earnings per share for the current fiscal year.
Johnson Matthey Cuts Dividend
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on JMAT. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 1,800 ($22.16) price target on shares of Johnson Matthey in a research note on Tuesday, December 17th. Berenberg Bank decreased their target price on Johnson Matthey from GBX 1,650 ($20.31) to GBX 1,500 ($18.47) and set a “hold” rating on the stock in a research report on Thursday, November 28th.
Check Out Our Latest Stock Report on Johnson Matthey
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Further Reading
- Five stocks we like better than Johnson Matthey
- How to Use Stock Screeners to Find Stocks
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Canadian Penny Stocks: Can They Make You Rich?
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What is Put Option Volume?
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.